Dynatronics Co. (NASDAQ:DYNT – Get Rating) was the target of a large decline in short interest in the month of July. As of July 31st, there was short interest totalling 143,400 shares, a decline of 9.8% from the July 15th total of 158,900 shares. Based on an average daily trading volume, of 27,400 shares, the short-interest ratio is presently 5.2 days. Currently, 1.1% of the shares of the company are short sold.
Dynatronics Price Performance
DYNT stock traded down $0.02 during trading on Wednesday, reaching $0.62. 54,457 shares of the company were exchanged, compared to its average volume of 40,617. The company has a 50-day moving average of $0.65 and a two-hundred day moving average of $0.70. The company has a market capitalization of $11.35 million, a price-to-earnings ratio of -62,340.00 and a beta of 0.14. Dynatronics has a twelve month low of $0.43 and a twelve month high of $1.62. The company has a debt-to-equity ratio of 0.13, a current ratio of 2.03 and a quick ratio of 0.89.
Analysts Set New Price Targets
Several brokerages recently commented on DYNT. StockNews.com began coverage on shares of Dynatronics in a report on Wednesday. They set a “hold” rating for the company. Lake Street Capital started coverage on shares of Dynatronics in a report on Wednesday, July 27th. They issued a “buy” rating and a $4.00 price objective for the company. One equities research analyst has rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, Dynatronics presently has an average rating of “Moderate Buy” and an average price target of $3.50.
Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. Its orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products.
- Get a free copy of the StockNews.com research report on Dynatronics (DYNT)
- Agilent Technologies Proves Its Worth VS Illumina
- Lowe’s Stands Out Amid Q2 Retail Reports
- Target’s Results Cap Upside Potential For Retail Stocks
- Are These 3 Video Game Stocks Now In Play?
- 2 Long-Term EV Plays Trading Under $20
Receive News & Ratings for Dynatronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics and related companies with MarketBeat.com's FREE daily email newsletter.